1827. Genetic Characterization of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates Associated with the Development of Reduced Susceptibility to Vancomycin from Latin America

BACKGROUND: Vancomycin (VAN) is a first-line therapeutic option for severe MRSA infections, especially in Latin America where other options are limited. However, reduced susceptibility to VAN may lead to therapeutic failures. The molecular mechanisms leading the development of VAN-intermediate S. au...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Liliana Vargas Ardila, Monica, Castro-Cardozo, Betsy E, Rios, Rafael, Hernandez, Angie K, Millan, Lina V, Carvajal, Lina P, Seas, Carlos, Munita, Jose M, Arias, Cesar A, Reyes, Jinnethe, Diaz, Lorena
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808870/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz359.089
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars